Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Prospects for Improving Outcomes in High-Risk Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Newer Options for Durable Disease Control in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Therapeutic Sequencing in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Investigational and Emerging Therapies for Diffuse Large B-Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Jeremy S. Abramson, MD, MMSc; Matthew J. Matasar, MD

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Double-Hit Relapsed/Refractory Diffuse Large B-Cell Lymphoma

clinical topic updates
By Matthew J. Matasar, MD